March 21, 2024 News by Mary Chapman Seqster data-sharing platform selected to power MSAA network Note: This story was updated March 26, 2024, to correct the affiliations of the Multiple Sclerosis Implementation Network staff and to note changes to the program’s partners. The Multiple Sclerosis Association of America (MSAA) has tapped healthcare technology company SeqsterĀ to power its multicenter research and learning program, which…
March 15, 2024 News by Andrea Lobo, PhD Metabolon, Cardiff University partner for MS biomarker research Metabolon and Cardiff University are partnering to discover new biomarkers that could help better understand disease mechanisms and develop new treatments for multiple sclerosis (MS). The project leverages Metabolon’s expertise in metabolomics, a field of research that measures all products of metabolism, called metabolites, that are made…
January 20, 2022 News by Lindsey Shapiro, PhD Cyxone to Scale Up Production of T20K, Plant-derived Therapy for MS Cyxone will work with a European organization to scale up production of the active ingredient in T20K, its experimental treatment for multiple sclerosis (MS), the company announced. The collaboration, which will cover the development of a new manufacturing method and later the…
October 12, 2021 News by Patricia Inacio, PhD Innodem, Novartis Team Up on Trial Testing Eye-tracking Technology Innodem Neurosciences is teaming up with Novartis Canada on a breakthrough clinical trial to evaluate if Innodemās digital biomarker eye-tracking technology can monitor disease progression in people with multiple sclerosis (MS). The trial will test Innodem’s “easy-to-use, affordable technology,” which works using visible light, with no special infrared…
August 18, 2021 News by Marta Figueiredo, PhD Collaboration Explores Therapies for Autoimmune Diseases Cytocom has joined forces with La Jolla Institute for Immunology (LJI) to discover and develop new immune-modulating therapies targeting toll-like receptors (TLRs) for autoimmune diseases such as multiple sclerosisĀ (MS), cancer, and infectious and chronic inflammatory conditions. TLRs are an important family of protein receptors found at the surface…
June 2, 2021 News by Marta Figueiredo, PhD Qynapse Announces Research Collaborations for World MS Day Qynapse, a company that combines artificial intelligence with neuroimaging technology, is reaffirming its commitment to help advance multiple sclerosis (MS) research and care in recognition of World MS Day. World MS Day is officially celebrated on May 30, with global events and activities designed to raise disease awareness.
January 14, 2021 News by Forest Ray PhD Public-private Partnership Will Assess Therapy Potential, Effects of CBD Open Book Extracts (OBX) and Case Western Reserve University School of Medicine have partnered to investigate how cannabinoids like CBD affect brain cells, particularly in regard to neuroinflammation, according to an OBX press release. CBD (cannabidiol) and other cannabinoids, such as THC (tetrahydrocannabinol), have attracted interest for…
November 4, 2020 News by Mary Chapman Innovation Challenge Seeks Solutions From Entrepreneurs in MS Community A $25,000 contest is inviting entrepreneurs who have multiple sclerosis (MS), or take care of someone with MS, to pitch their non-therapeutic solutions for people with the neurodegenerative disorder. The virtual Innovation Challenge, which takes place in March 2021, is part of a collaboration between patient-powered platform Lyfebulb…
September 23, 2020 News by Teresa Carvalho, MS Siemens Healthineers, Novartis Partner to Develop NfL Diagnostic Test The development of a diagnostic test using neurofilament light chain (NfL) ā a biomarker for nerve cell damage ā for people with multiple sclerosis (MS) will be part of a collaboration program between Siemens HealthineersĀ and Novartis. The goal of this new collaboration is to design, develop,…
January 17, 2020 News by Vanessa Pataia BioMed X, Merck Start Research Project for Autoimmune Diseases, Including MS BioMed XĀ announced a new collaboration with MerckĀ to create a joint research group to investigate the role of the intestinal epithelial barrier in the development and progression of autoimmune diseases, includingĀ multiple sclerosis (MS). The intestinal epithelial barrier is a physical border between the gut and the rest…
December 12, 2018 News by Mary Chapman GB Sciences, LSU Partner on Cannabinoid Research and Development Project for MS, Other Diseases As debate continues about the effects of medical marijuana on multiple sclerosis (MS) and other diseases, cannabis companyĀ GB SciencesĀ and Louisiana State UniversityĀ (LSU) have agreed on a cannabinoid research and development project. This collaboration between a public and a private enterprise is a first in the therapeutic cannabis…
October 31, 2018 News by Mary Chapman Collaboration Formed to Further MS Education, and to Help MS Caregivers Can Do Multiple Sclerosis and Embracing Carers are collaborating to help caregivers better understand the effects of multiple sclerosis (MS), and to help them take better care of themselves. The collaboration enlisted Can Do MS, which delivers health and wellness education programs to families living with MS, to…
February 19, 2018 News by Patricia Silva, PhD Accelerated Cure Project, Regeneron Unit to Sequence Coding Portion of MS Patients’ Genes The Accelerated Cure Project for Multiple SclerosisĀ and a Regeneron unitĀ are teaming up to sequence the coding portion of genes in DNA samples ofĀ multiple sclerosisĀ and other patients in the project’s repository. The cure project is a non-profit organization whose goal is to accelerate research to improve MS diagnosis and…
January 24, 2017 News by Patricia Silva, PhD University of Maryland and VA to Investigate Tregs as Possible MS Treatment The VA Maryland Health Care System (VAMHCS) and the University of Maryland Fischell Department of BioengineeringĀ areĀ collaborating in a research initiative that aims to increase our understanding of multiple sclerosis (MS). The project is being led by Christopher M. Jewell, PhD, an assistant professor in bioengineering. Jewell will…